Get started
Author

Lukas D. Streich

Observed name: Lukas Streich
ORCID: 0000-0002-4275-093X
Observed ORCID: 0000-0002-4275-093X
OpenAlex ID: A5089713330
Aggressive morphologic variants of mantle cell lymphoma characterized with high genomic instability showing frequent chromothripsis, CDKN2A /B loss, and TP53 mutations: A multi‐institutional study
2020 · Lukas Streich, Madina Sukhanova, et al. · Genes Chromosomes and Cancer · 23
Inflammatory leiomyosarcoma/rhabdomyoblastic tumor: A report of two cases with novel genetic findings
2022 · Madina Sukhanova, Farres Obeidin, et al. · Genes Chromosomes and Cancer · 19
Chondroid Synoviocytic Neoplasm: A Clinicopathologic, Immunohistochemical, and Molecular Genetic Study of a Distinctive Tumor of Synoviocytes
2024 · Erica Y. Kao, Fisun Ardic, et al. · Modern Pathology · 14
PDF
SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression
2022 · Mariafausta Fischietti, Frank Eckerdt, et al. · Cancer Research Communications · 14
Solitary fibrous tumor of thoracic cavity, extra-thoracic sites and central nervous system: Clinicopathologic features and association with local recurrence and metastasis
2021 · Borislav A. Alexiev, Brian S. Finkelman, et al. · Pathology - Research and Practice · 8
Synovial sarcoma with overwhelming glandular (adenocarcinoma-like) component: A case report and review of the literature
2021 · Lukas Streich, Daniel N. Johnson, et al. · Pathology - Research and Practice · 7
Diagnosis of giant cell-rich bone tumors on core needle biopsy: A practical approach
2022 · Lucy Jager, Daniel N. Johnson, et al. · Pathology - Research and Practice · 6
Hibernoma with inflammatory features: A description of a new variant
2020 · Lukas Streich, Ximing Yang · Human Pathology Case Reports · 5
PDF
Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase
2023 · Emmanuella Oyogoa, Lukas Streich, et al. · Frontiers in Oncology · 3
PDF
Data from SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression
2023 · Mariafausta Fischietti, Frank Eckerdt, et al.
Supplementary Figures S1-S3, Table S1 from SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression
2023 · Mariafausta Fischietti, Frank Eckerdt, et al.
Supplementary Table S4 from SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression
2023 · Mariafausta Fischietti, Frank Eckerdt, et al.
Supplementary Table S2 from SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression
2023 · Mariafausta Fischietti, Frank Eckerdt, et al.
Supplementary Table S3 from SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression
2023 · Mariafausta Fischietti, Frank Eckerdt, et al.
Supplementary Table S2 from SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression
2023 · Mariafausta Fischietti, Frank Eckerdt, et al.
Supplementary Figures S1-S3, Table S1 from SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression
2023 · Mariafausta Fischietti, Frank Eckerdt, et al.
Supplementary Table S4 from SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression
2023 · Mariafausta Fischietti, Frank Eckerdt, et al.
Supplementary Table S3 from SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression
2023 · Mariafausta Fischietti, Frank Eckerdt, et al.
Data from SLFN11 Negatively Regulates Noncanonical NFκB Signaling to Promote Glioblastoma Progression
2023 · Mariafausta Fischietti, Frank Eckerdt, et al.
Works count: 19
Citation count: 99
H-index: 6
I10-index: 4
Year
Topic
Type